Kimia Biosciences Ltd.

Financial

	Kimia Biosciences	Coral Laboratories	Krebs Biochem.&Inds
Operational Metrics
Unclassified
R&D as a % of Total Sales	4.19 %	n/a	n/a
Financials
5 yr Average ROE	-352.38 %	6.99 %	56.46 %
5yr average Equity Multiplier	65.1	1.2	-2.97
5yr Average Asset Turnover Ratio	1.17	0.47	0.3
5yr Avg Net Profit Margin	-2.03 %	12.64 %	-60.0 %
Price to Book	0.0	0.87	0.0
P/E	17.43	9.81	0.0
5yr Avg Cash Conversion Cycle	28.76 Days	26.14 Days	-861.42 Days
Inventory Days	94.07 Days	79.65 Days	115.42 Days
Days Receivable	101.18 Days	112.59 Days	8.79 Days
Days Payable	144.79 Days	147.17 Days	408.94 Days
5yr Average Interest Coverage Ratio	0.28	114.88	-5.02
5yr Avg ROCE	-0.98 %	8.79 %	-22.06 %
5yr Avg Operating Profit Margin	1.32 %	11.85 %	-38.55 %
5 yr average Debt to Equity	29.7	0.03	-2.12
5yr CAGR Net Profit	n/a	17.24 %	-7.31 %
5yr Average Return on Assets	-2.12 %	5.83 %	-17.59 %
Shareholdings
Promoter Holding	74.94 %	71.51 %	72.74 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.0	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Kimia Biosciences	Coral Laboratories	Krebs Biochem.&Inds
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Formulation of Medicine 0 Sabam-RSS 0 Simvastatin 0 Phenylephrine 0	Product Wise Break-Up Formulations 100.0 Simvastatin 0 Pharmaceutical 0 Phenylephrine 0 Sabam-RSS 0	Product Wise Break-Up Formulation of Medicine 0 Simvastatin 13.01 Pharmaceutical 0 Phenylephrine 62.86 Sabam-RSS 0 Others 24.13
Location Wise Break-Up	Location Wise Break-Up Domestic 81.72 International 18.28 Rest of the World 0 India 0 Ethiopia 0	Location Wise Break-Up Rest of the World 57.87 International 0 Domestic 0 Ethiopia 21.5 India 19.05 Others 1.58	Location Wise Break-Up Rest of the World 0 International 0 Domestic 0 Ethiopia 0 India 100.0